SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000849146-19-000064
Filing Date
2019-08-14
Accepted
2019-08-14 16:11:36
Documents
16
Period of Report
2019-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kearningsrelease.htm   iXBRL 8-K 42664
2 EXHIBIT 99.1 lfvnq42019earningsrele.htm EX-99.1 414360
8 logoa16.jpg GRAPHIC 6462
  Complete submission text file 0000849146-19-000064.txt   636059

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20190814.xsd EX-101.SCH 4591
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20190814_cal.xml EX-101.CAL 626
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20190814_def.xml EX-101.DEF 1476
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20190814_lab.xml EX-101.LAB 27263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20190814_pre.xml EX-101.PRE 14116
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-kearningsrelease_htm.xml XML 4824
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 191026461
SIC: 2834 Pharmaceutical Preparations